608
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Screening and identification of novel inhibitors against human 4-aminobutyrate-aminotransferase: A computational approach

, , , &
Pages 210-219 | Received 28 Jan 2018, Accepted 27 May 2018, Published online: 06 Mar 2019

References

  • P.L.McGeerT.KawamataD.G.WalkerH.I.AkiyamaE.G.Tooyama McGeerMicroglia in degenerative neurological diseaseGlia719938492
  • L.K.Medina-KauweA.J.TobinL.De MeirleirJ.JaekenC.JakobsW.L.Nyhanet al.4-Aminobutyrate aminotransferase (4-aminobutyrate aminotransferase-transaminase) deficiencyJ Inherit Metab Dis221999414427
  • B.Sabeega BegumS.SubashiniP.HemalathaP.ArchanaN.BharathiP.Nagarajanet al.In silico screening of phytochemical compounds targeting childhood absence epilepsy (CAE)Int J Pharm Pharm Sci62014430433
  • L.M.GunneJ.E.HaggstromB.SjoquistAssociation with persistent neuroleptic-induced dyskinesia of regional changes in brain 4-aminobutyrate aminotransferase synthesisNature3091984347359
  • J.ButterworthC.M.YatesJ.SimpsonPhosphate-activated glutaminase in relation to Huntington’s disease and agonal stateJ Neurochem411983440447
  • S.YoshikaY.AsoY.TakedaStatical evaluation of accelerated stability data obtained at a single temperature. Effect of experimental errors in evaluation of stability dataChem Pharma Bullet38199017571759
  • R.A.E.BakayA.HarrisNeurotransmitter receptor and biochemical changes in monkey cortical epileptic fociBrain Res2061981 387-04
  • N.NishinoH.FujiwaraS.A.Noguchi-KunoC.Tanaka4-Aminobutyrate aminotransferase A receptor but not musculleric receptor density was decreased in the brain of patients with Parkinson's diseaseJap J Pharmacol481988331339
  • K.A.C.ElliottF.HobbigerGamma aminobutyric acid: circulatory and respiratory effects in different species; re-investigation of the anti-strychnine action in miceJ Physiol119597084
  • Y.AokiN.Saint-GermainM.GydaE.Magner-FinkY.E.LeeC.Credidioet al.Sox10 regulates the development of neural crest-derived melanocytes in XenopusDev Biol25920033339
  • K.InoueT.ShiraiH.OchiaiM.KasaoK.HayakawaM.Kimuraet al.Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (4-aminobutyrate aminotransferase) in mild hypertensivesEur J Clin Nutr572003490495
  • A.NoguchiS.MatsumuraM.DezawaM.TadaT.YanazawaA.Itoet al.Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brainsJ Biol Chem28420093289532905
  • O.C.SneadBasic mechanisms of generalized absence seizuresAnn Nuerol371995146157
  • http://www.who.int/mediacentre/news/releases/2007/pr04/en/.
  • E.PeruccaThe new generation of antiepileptic drugs: advantages and disadvantagesBrit J Clin Pharmacol421996531543
  • D.S.HillB.J.WlodarczykA.M.PalaciosR.H.FinnellTeratogenic effects of antiepileptic drugsExpert Rev Neurother102010943959
  • TakashiAkihiroSatoshiKoikeRyojiTaniTakehiroTominagaShinWatanabeYokoIijimaKohAokiDaisukeShibataHiroshiAshiharaChiakiMatsukuraBiochemical mechanism on 4-aminobutyrate aminotransferase accumulation during fruit development in tomatoPlant Cell Physiol499200813781389
  • G.Phani KumarF.KhanumNeuroprotective potential of phytochemicalsPharmacogn Rev620128190
  • A.G.AtanasovB.WaltenbergerE.M.P.Wenziget al.Discovery and resupply of pharmacologically active plant-derived natural products: a reviewBiotechnol Adv332015 1582-14
  • A.M.AbdouS.HigashiguchiK.HorieM.KimH.HattaH.Yokogoshiet al.Relaxation and immunity enhancement effects of gamma-aminobutyric acid (4-aminobutyrate aminotransferase) administration in humansBiofact262006201208
  • V.ChintamunneeM.F.MahomoodallyHerbal medicine commonly used against infectious diseases in the tropical island of MauritiusJ Herb Med1432012113125
  • J.TahraouiZ.El-HilalyH.IsrailiZ.LyoussiEthnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province)J Ethnopharmacol1102007105117
  • www.uniprot.org.
  • www.chemspider.com.
  • Prime 2011 version 2.1 Schrödinger, LLC, NewYork.
  • V.K.VyasR.D.UkawalaM.GhateC.ChinthaHomology modeling a fast tool for drug discovery: current perspectivesInd J Pharm Sci742012117
  • Site Map version 2.5 Schrodinger, LLC, New York, 2016.
  • K.GinalskiV.NickV.GrishinA.GodzikL.RychlewskiPractical lessons from protein structure predictionNucleic Acid Res33200518741891
  • J.C.RobertsonN.C.HurleyM.TortoriciG.CiossaniM.T.BorrelloN.T.Velloreet al.Expanding the druggable space of the LSD1/CoREST epigenetic target: new potential binding regions for drug-like molecules, peptides, protein partners, and chromatinJ Compu Biol92013e1003158
  • LigPrep, 2011. Version 2.3 Schrödinger, LLC, NewYork.
  • S.K.TripathiR.MuttineniS.K.SinghExtra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitorsJ Theor Biol334201387100
  • K.K.KakaralaJ.KaiserD.VinodStructure and putative signaling mechanism of Protease activated receptor 2 (PAR2) – a promising target for breast cancerJ Mol Graph Model542014179199
  • Glide, 2011.version5.7, Schrödinger, LLC, NewYork.
  • K.M.ElokelyR.J.DoerksenDocking challenge: protein sampling and molecular docking performanceJ Chem Inf Model53201319341945
  • QikProp, version 4.3, Schrödinger, LLC, New York, NY, 2014.
  • T.KatsilaG.A.SpyrouliasG.P.PatrinosG.T.MatsoukasComputational approaches in target identification and drug discoveryComp Struct Biotechnol142016177184
  • T.IftikharS.BatoolA.DeepB.NarasimhanP.C.SharmaM.Malhotraet al.In silico analysis of the inhibitory activities of 4-aminobutyrate aminotransferase derivatives on 4-aminobutyrate transaminaseArab J Chem10201712671275
  • S.SubhaniJ.ArchanaK.JamilHomology modelling and molecular docking of MDR1with chemotherapeutic agents in non-small cell lung cancerBiomed Pharmaco71201545
  • S.SubhaniK.JamilMolecular docking of chemotherapeutic agents to CYP3A4 in non-small cell lung cancerBiomed Pharmaco7320156574
  • S.VijayakumarP.ManogarS.PrabhuPotential therapeutic targets and the role of technology in developing novel cannabinoid drugs from cyanobacteriaBiomed Pharmaco832016362371
  • A.O.M.PatschullB.GooptuP.AshfordT.DaviterI.NobeliIn silico assessment of potential druggable pockets on the surface of α1-antitrypsin conformersPLoS One72012e36612
  • T.LiuF.XuX.DuD.LaiT.LiuY.Zhaoet al.Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1Mol Cell Biochem3402010265273
  • S.AkhondzadehM.NoroozianM.MohammadiS.OhadiniaA.H.JamshidiM.Khaniet al.Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trialJ Neurol Neurosurg Psychia742003863866
  • B.B.AggarwalA.KumarA.C.BhartiAnticancer potential of curcumin: preclinical and clinical studiesAntican Res232003363398
  • M.ParamasivamR.PoiH.BanerjeeA.BandyopadhyayHigh-performance thin layer chromatographic method for quantitative determination of curcuminoids in Curcuma longa L germplasmFood Chem1132009640644
  • M.ErfaniF.ArshrafzadehJ.AkhondianH.RahimiM.B.ToosiH.L.Kalatet al.The effect of curcumin on epilepsy: an experimental reviewRev Clinical Med42017131135
  • G.M.Masud ParvezCurrent advances in pharmacological activity and toxic effects of various capsicum speciesJ Pharmaco Phytochem3201719001912